Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 851 to 875 of 2013

TitleReference numberPublishedLast updated
Insect bites and stings: antimicrobial prescribingNG182
Dupilumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal)TA648
Axonics sacral neuromodulation system for treating refractory overactive bladderHTG554
Implantable cardiac monitors to detect atrial fibrillation after cryptogenic strokeHTG553
Glasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal)TA646
Eculizumab for treating relapsing neuromyelitis optica (terminated appraisal)TA647
High-sensitivity troponin tests for the early rule out of NSTEMIHTG552
Anaphylaxis: assessment and referral after emergency treatmentCG134
Surgical site infections: prevention and treatmentNG125
Perioperative care in adultsNG180
Rehabilitation for adults with complex psychosisNG181
Entrectinib for treating ROS1-positive advanced non-small-cell lung cancerTA643
Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphomaTA641
Gilteritinib for treating relapsed or refractory acute myeloid leukaemiaTA642
Deep brain stimulation for refractory epilepsy in adultsHTG550
Implanted vagus nerve stimulation for treatment-resistant depressionHTG551
Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplantTA640
Transcranial magnetic stimulation for obsessive-compulsive disorderHTG548
Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney diseaseHTG549
Artificial iris insertion for acquired aniridiaHTG546
Artificial iris insertion for congenital aniridiaHTG547
Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancerTA638
Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancerTA639
Ranibizumab for treating diabetic retinopathy (terminated appraisal)TA637
Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma (terminated appraisal)TA634

Results per page

  1. 10
  2. 25
  3. 50
  4. All